Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are one of the most maturely designed TPD methods. In this critique, we center on both of those preclinical experiments and scientific trials to deliver a comprehensive summary of the protection and scientific usefulness of PROTACs and MGDs in hematologic malignancies over https://lukasyskbt.activosblog.com/31221315/fema-4774-fundamentals-explained